Guo Yan, Li Hua-Ming, Zhu Wei-Qin, Li Zhen
Department of Gastroenterology, Hangzhou Third People's Hospital, Hangzhou, 310009, People's Republic of China.
Clin Cosmet Investig Dermatol. 2021 Feb 5;14:129-136. doi: 10.2147/CCID.S293737. eCollection 2021.
To investigate the role of (HP) eradication in chronic spontaneous urticaria (CSU) treatment.
Retrospective analysis was performed on the clinical data of 522 patients with CSU who underwent a HP breath test in Hangzhou Third People's Hospital between January 2018 and December 2019. The CSU-HP(+) group consisted of patients with CSU and HP infection, who were treated with antihistamines combined with HP eradication therapy. The CSU-HP(-) group consisted of patients with CSU alone, who were treated with antihistamines. Propensity score matching (PSM) analysis, using the nearest neighbor matching method on a 1:1 basis, was performed to ensure the characteristics of the CSU-HP(+) and CSU-HP(-) groups were similar. Factors, including age, gender, white blood cells, red blood cells, platelets, alanine transaminase, creatinine, immunoglobulin E, and pre-treatment urticaria activity score (UAS), were matched to obtain a balanced cohort of patients in each group. Therapeutic effects were compared after matching. -tests, test, and McNemar's test were used for comparison between the two groups before and after matching.
Patients in the CSU-HP(+) group reported significantly more gastrointestinal symptoms than those in the CSU-HP(-) group. UAS scores in the second week of treatment were significantly different between the two groups. After 3 months, the recurrence rate in the CSU-HP(+) group was lower than in the CSU-HP(-) group.
Eradication of HP infection in patients with CSU helps relieve gastrointestinal symptoms, improves the therapeutic effect of CSU within 2 weeks, and reduces the recurrence rate 3 months after treatment.
探讨幽门螺杆菌(HP)根除在慢性自发性荨麻疹(CSU)治疗中的作用。
对2018年1月至2019年12月在杭州市第三人民医院接受HP呼气试验的522例CSU患者的临床资料进行回顾性分析。CSU-HP(+)组由CSU合并HP感染患者组成,采用抗组胺药联合HP根除治疗。CSU-HP(-)组由单纯CSU患者组成,采用抗组胺药治疗。采用倾向评分匹配(PSM)分析,以1:1的最近邻匹配法确保CSU-HP(+)组和CSU-HP(-)组的特征相似。对年龄、性别、白细胞、红细胞、血小板、丙氨酸转氨酶、肌酐、免疫球蛋白E和治疗前荨麻疹活动评分(UAS)等因素进行匹配,以获得每组均衡的患者队列。匹配后比较治疗效果。采用t检验、χ²检验和McNemar检验对两组匹配前后进行比较。
CSU-HP(+)组患者的胃肠道症状明显多于CSU-HP(-)组。两组治疗第二周的UAS评分有显著差异。3个月后,CSU-HP(+)组的复发率低于CSU-HP(-)组。
根除CSU患者的HP感染有助于缓解胃肠道症状,在2周内提高CSU的治疗效果,并降低治疗后3个月的复发率。